Hansa Biopharma AB (publ) (STO:HNSA)

Hansa Biopharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	405.28	732.06	1,496	651.34	1,139
Short-Term Investments	-	-	-	237.62	238.14
Cash & Short-Term Investments	405.28	732.06	1,496	888.96	1,378
Cash Growth	-44.64%	-51.07%	68.31%	-35.47%	129.17%
Accounts Receivable	144.97	78.03	42.96	9.71	0.11
Other Receivables	17.49	15.73	24.22	13.53	7.59
Receivables	162.46	93.76	67.18	23.24	7.7
Inventory	2.61	1.51	0.97	0.24	0.1
Prepaid Expenses	2.84	3.06	3.52	3.34	1.66
Other Current Assets	12.24	24.76	36.85	26.56	6.43
Total Current Assets	585.43	855.15	1,605	942.34	1,393
Property, Plant & Equipment	17.88	27.07	35.84	41.71	9.7
Other Intangible Assets	20.46	23.17	26.01	28.76	31.41
Long-Term Deferred Charges	176.88	112.65	20.85	-	-
Total Assets	800.64	1,018	1,687	1,013	1,434
Accounts Payable	37.62	86.97	62.48	53.36	26.67
Accrued Expenses	97.89	116.54	100.32	78.22	52.36
Current Portion of Leases	7.68	7.5	7.17	6.89	4.42
Current Income Taxes Payable	2.71	1.6	0.6	-	0.13
Current Unearned Revenue	16.33	41.47	40.43	24.96	17.41
Other Current Liabilities	93.45	66.91	53.71	7.79	13.22
Total Current Liabilities	255.69	320.99	264.71	171.22	114.2
Long-Term Debt	1,065	844.9	762.6	-	-
Long-Term Leases	6.68	14.36	21.33	28.49	0.63
Long-Term Unearned Revenue	-	-	29.5	47.02	62.03
Long-Term Deferred Tax Liabilities	0.17	0.37	0.41	0.43	0.42
Other Long-Term Liabilities	63.3	5.3	5.95	8.08	15.09
Total Liabilities	1,390	1,186	1,084	255.24	192.37
Common Stock	67.81	55.03	55.03	46.34	45.9
Additional Paid-In Capital	3,451	3,083	3,022	2,573	2,509
Retained Earnings	-4,110	-3,303	-2,471	-1,860	-1,312
Treasury Stock	-	-2.36	-2.59	-1.86	-1.42
Comprehensive Income & Other	0.94	-0.41	0.01	0.13	-0.14
Shareholders' Equity	-589.83	-167.88	602.91	757.57	1,242
Total Liabilities & Equity	800.64	1,018	1,687	1,013	1,434
Total Debt	1,079	866.77	791.09	35.38	5.05
Net Cash (Debt)	-673.73	-134.71	705.09	853.58	1,372
Net Cash Growth	-	-	-17.40%	-37.81%	131.98%
Net Cash Per Share	-10.72	-2.56	15.70	19.19	32.54
Filing Date Shares Outstanding	67.81	52.67	52.44	44.47	44.47
Total Common Shares Outstanding	67.81	52.67	52.44	44.47	44.47
Working Capital	329.74	534.16	1,340	771.12	1,279
Book Value Per Share	-8.70	-3.19	11.50	17.03	27.93
Tangible Book Value	-610.29	-191.05	576.9	728.81	1,211
Tangible Book Value Per Share	-9.00	-3.63	11.00	16.39	27.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.